Skip to content
OpenCapital
Get started

NewAmsterdam Pharma Company NAMS Goodwill

Goodwill at other companies

Merck & Co. logo
Merck & Co.MRK
$21.58B-0.5%
Amgen logo
AmgenAMGN
$18.67B+0.2%
Eli Lilly logo
Eli LillyLLY
$6.13B+6.2%

Other financials

Income statement

See full
Revenue$3.0M+2.1%
Operating income-$58.4M+15.2%
Net income-$48.4M-22.6%
EPS (diluted)-$0.40-17.6%

Balance sheet

See full
Cash & equivalents$457.6M-38.9%
Total debt$23.0K-94.1%
Total equity$665.2M-14.4%
Total assets$732.6M-10.5%

Cash flow

See full
Operating cash flow-$30.6M+16.1%
CapEx$38.0K+138%
Free cash flow-$30.6M+16.0%

Valuation

See full
Market cap$3.67B+63.7%

Profitability

See full
Operating margin-953.6%-3,536pp
Net margin-942.8%-3,477pp
FCF margin-630.1%-6,324pp

Returns & leverage

See full
Return on equity-29.5%-1.8pp
Current ratio9.8×-10.2×

Where this comes from

Reported directly by NewAmsterdam Pharma Company in its filing.

Tagged under the XBRL concept us-gaap:IntangibleAssetsNetIncludingGoodwill.

The official record: NewAmsterdam Pharma Company’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about NewAmsterdam Pharma Company's goodwill.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is NewAmsterdam Pharma Company's goodwill?
NewAmsterdam Pharma Company (NAMS) reported goodwill of $375K in Q1 2026.
How has NewAmsterdam Pharma Company's goodwill changed year-over-year?
NewAmsterdam Pharma Company's goodwill decreased by 25.3% year-over-year, from $502K to $375K.
What is the long-term trend for NewAmsterdam Pharma Company's goodwill?
Over 3 years (2022 to 2025), NewAmsterdam Pharma Company's goodwill has grown at a 25.1% compound annual growth rate (CAGR), from $208K to $407K.
What does goodwill mean?
The excess of acquisition cost over the fair value of net identifiable assets acquired — representing brand value, customer relationships, and synergies from past M&A.